FDA Approves New Animal Drug for Bacterial Infections in Dogs and Cats

Summary

The FDA is updating its regulations to reflect the approval of a new animal drug, filed by Intervet, Inc., which allows for the veterinary prescription use of an oral suspension containing orbifloxacin to treat various bacterial infections in dogs and cats.